Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fleet Enema vs Pico Salax for Transanal Endoscopic Surgery (TESEO)
NCT05148494Phase 4Recruiting
- Sponsor
- Nova Scotia Health
- Start
- Mar 2022
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of sodium phosphate and sodium picosulfate + magnesium oxide + citric acid in colorectal neoplasm (2 arms), sponsored by Nova Scotia Health. Primary endpoint: Quality of bowel preparation. Started Mar 2022; status: recruiting.
02
Drugs
sodium phosphatesodium picosulfate + magnesium oxide + citric acid
03
Conditions
colorectal neoplasm
Beyond the preview
Go deeper on NCT05148494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05148494.